Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis

Journal of Investigative Medicine

Volumn 60, Issue 6, 2012, Pages 898-901

  Xu, Qin ^a   Sun, Xue Cheng ^a   Shang, Xiao Peng ^a   Jiang, Hou Sen ^a  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

CXCL12; Osteoarthritis; Severity; Synovial fluid

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; KELLGREN LAWRENCE GRADING SYSTEM; KNEE; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RATING SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

CASE-CONTROL STUDIES; CHEMOKINE CXCL12; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SYNOVIAL FLUID;

EID: 84864612753     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31825f9f69     Document Type: Article

References (28)

1. Honsawek S, Tanavalee A, Yuktanandana P, et al. Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. Musculoskelet Disord. 2010;11:257.
2. Felson DT, Zhang Y, Hannan MT, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995;38:1500-1505.
3. Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 2006;354:841-848.
4. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 2005;44:7-16.
5. Cheng T, Li FF, Zhao S, et al. Soluble P selectin in synovial fluid level is correlated with the radiographic severity of knee osteoarthritis. Clin Chim Acta. 2010;411:1529-1531.
6. Stannus O, Jones G, Cicuttini F, et al. Circulating levels of IL-6 and TNF-> are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage. 2010;18:1441-1447.
7. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol. 1997;24:1486-1488.
8. Conrozier T, Carlier MC, Mathieu P, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis. 2000;59:828-831.
9. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001;250:91-104.
10. Yuan GH, Masuko-Hongo K, Nishioka K. Role of chemokines/ chemokine receptor systems in cartilage degradation. Drug News Perspect. 2001;14:591-600.
11. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev. 2000;177:175-184.
12. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002;46:130-137.
13. Wei L, Sun X, Kanbe K, et al. Chondrocyte death induced by pathological concentration of chemokine stromal cell-derived factor-1. J Rheumatol. 2006;33:1818-1826.
14. Kanbe K, Takemura T, Takeuchi K, et al. Synovectomy reduces stromalcell- derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br. 2004;86:296-300.
15. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.
16. Saxne T, Lindell M, Ma?nsson B, et al. Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology (Oxford). 2003;42:903-904.
17. Appelboom T, Emery P, Tant L, et al. Evaluation of technetium-99m- ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford). 2003;42:1179-1182.
18. Baddour VT, Bradley JD. Clinical assessment and significance of inflammation in knee osteoarthritis. Curr Rheumatol Rep. 1999;1:59-63.
19. Katschke KJ Jr, Rottman JB, Ruth JH, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001;44:1022-1032.
20. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
21. Lotz M, Blanco FJ, von Kempis J, et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl. 1995;43:104-108.
22. Chiu YC, Yang RS, Hsieh KH, et al. Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes. Mol Pharmacol. 2007;72:695-703.
23. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002;46:130-137.
24. Li NG, Shi ZH, Tang YP, et al. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem. 2011;18:977-1001.
25. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage. 1999;7:371-373.
26. Lajeunesse D, Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol. 2003;15:628-633.
27. Mansell JP, Bailey AJ. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest. 1998;101:1596-1603.
28. Lisignoli G, Toneguzzi S, Piacentini A, et al. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol. 2006;206:78-85.